| 國家衛生研究院 |
2023-10-24 |
Drastic synergy of lovastatin and antrodia camphorata extract combination against PC3 androgen-refractory prostate cancer cells, accompanied by AXL and stemness molecules inhibition
|
Yao, CJ;Chang, CL;Hu, MH;Liao, CH;Lai, GM;Chiou, TJ;Ho, HL;Kuo, HC;Yang, YY;Whang-Peng, J;Chuang, SE |
| 國立成功大學 |
2023 |
Managing the transition in cervical screening methods for Taiwan: Policy recommendations and perspectives
|
Chen, Chen C.-C.;Lai, C.-H.;Chang, Chang C.-L.;Cheng, W.-F.;Pwu, R.-F.;Tsai, J.;Wang, P.-H.;Whang-Peng, J.;Lai, G.-M. |
| 臺大學術典藏 |
2022-08-19T00:21:12Z |
Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer
|
Shiah H.-S.; Cheng A.-L.; CHIUN HSU; Hsu C.-H.; Liu T.-W.; Chang J.-Y.; Jan C.-M.; Chao Y.; Yu W.-L.; Chuang T.-R.; Whang-Peng J.; Chen L.-T. |
| 臺大學術典藏 |
2022-08-19T00:21:12Z |
Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer
|
Ch'ang H.-J.; Wang C.-C.; Cheng A.-L.; CHIUN HSU; Lu Y.-S.; Chang M.-C.; Lin J.-T.; Wang H.-P.; Shiah H.-S.; Liu T.-W.; Chang J.-Y.; Whang-Peng J.; Chen L.-T. |
| 臺大學術典藏 |
2022-08-19T00:21:02Z |
Clinical Development and Future Direction for the Treatment of Hepatocellular Carcinoma
|
Whang-Peng J.; Cheng A.-L.; CHIUN HSU; Chen C.-M. |
| 國家衛生研究院 |
2022-08-07 |
Selenium yeast and fish oil combination diminishes cancer stem cell traits and reverses cisplatin resistance in A549 sphere cells
|
Lai, IC;Liao, CH;Hu, MH;Chang, CL;Lai, GM;Chiou, TJ;Hsia, S;Tsai, WL;Lin, YY;Chuang, SE;Whang-Peng, J;Chen, HY;Yao, CJ |
| 臺大學術典藏 |
2022-06-10T06:11:06Z |
The aurora kinases inhibitor VE-465 is a novel treatment for glioblastoma multiforme
|
Lee P.-Y.; Chen C.-L.; ZHONG-ZHE LIN; Cheng A.-L.; Chen E.I.-T.; Whang-Peng J.; Huang C.-Y.F. |
| 臺大學術典藏 |
2022-05-05T09:10:22Z |
Development and Validation of an Instrument for the Measurement of Health-Related Quality of Life Based on View of Traditional Chinese Medicine Perspective
|
Chang H.-H.; WEI-CHU CHIE; Chin Y.-H.; Hsu C.-P.; Liu T.-W.; Whang-Peng J. |
| 臺大學術典藏 |
2021-12-01T02:30:47Z |
Reappraisal of the early diagnostic value of serial analyses of Western Blot patterns for HIV infection in Neonates
|
Chen M.-Y.; CHIEN-CHING HUNG; Lin Y.G.; Lin R.-Y.; Twu S.-J.; Ko Y.-C.; Ho H.-N.; Lin C.-P.; Huang S.-F.; Kerrigan M.E.; Whang-Peng J.; Chuang C.-Y.; Chang K.S.S.; Sung J.-L.; Chang H.-J.; Shih Y.-T.; Chang P.-Y. |
| 臺大學術典藏 |
2021-09-01T02:02:42Z |
Weekly CAF chemotherapy for advanced breast cancer patients
|
Hwang W.-S.; Hsiung C.A.; Ko W.-S.; lVang C.-C.; Chang J.-V.; Lai G.-M.; Hsieh R.-K.; Tsao C.-J.; Chen L.-T.; Law C.-K.; ANN-LII CHENG; Fan S.F.; Tzeng C.-H.; Chiou T.-J.; Whang-Peng J. |
| 臺大學術典藏 |
2021-09-01T02:02:34Z |
The significance of body weight change in non-Hodgkins lymphoma
|
Chin Y.H.; Liu J.M.; Tai J.J.; Chuang M.S.; Ho Y.L.; Chen Y.M.; Whang-Peng J.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T02:02:25Z |
Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma
|
ANN-LII CHENG; Hsiung C.A.; Su I.-J.; Chen P.-J.; Chang M.-C.; Tsao C.-J.; Kao W.-Y.; Uen W.-C.; Hsu C.-H.; Tien H.-F.; Chao T.-Y.; Chen L.-T.; Whang-Peng J. |
| 臺大學術典藏 |
2021-09-01T02:02:21Z |
Generation of Carcinoembryonic Antigen (CEA)-Specific T-Cell Responses in HLA-A*0201 and HLA-A*2402 Late-Stage Colorectal Cancer Patients after Vaccination with Dendritic Cells Loaded with CEA Peptides
|
Liu K.-J.; Wang C.-C.; Chen L.-T.; ANN-LII CHENG; Lin D.-T.; Wu Y.-C.; Yu W.-L.; Hung Y.-M.; Yang H.-Y.; Juang S.-H.; Whang-Peng J. |
| 臺大學術典藏 |
2021-09-01T02:02:17Z |
Gefitinib reverses chemotherapy resistance in gefitinib-insensitive multidrug resistant cancer cells expressing ATP-binding cassette family protein
|
Yang C.-H.; Huang C.-J.; Yang C.-S.; Chu Y.-C.; ANN-LII CHENG; Whang-Peng J.; Yang P.-C. |
| 臺大學術典藏 |
2021-09-01T02:02:15Z |
Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma
|
Chen L.-T.; Lin J.-T.; Tai J.J.; Chen G.-H.; Yeh H.-Z.; Yang S.-S.; Wang H.-P.; Kuo S.-H.; Sheu B.-S.; Jan C.-M.; Wang W.-M.; Wang T.-E.; Wu C.-W.; Chen C.-L.; Su I.-J.; Whang-Peng J.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T02:02:15Z |
Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and paclitaxel as first-line treatment
|
Yang C.-H.; Chen M.-C.; ANN-LII CHENG; Hsu C.-H.; Yeh K.-H.; Yu Y.-C.; Whang-Peng J.; Yang P.-C. |
| 臺大學術典藏 |
2021-09-01T02:02:14Z |
Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients
|
Su W.-P.; Wen C.-C.; Hsiung C.A.; Su I.-J.; ANN-LII CHENG; Chang M.-C.; Tsao C.-J.; Kao W.-Y.; Uen W.-C.; Hsu C.-H.; Lu Y.-S.; Tien H.-F.; Chao T.-Y.; Chen L.-T.; Whang-Peng J.; Chen P.-J. |
| 臺大學術典藏 |
2021-09-01T02:02:13Z |
Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer
|
Ch'ang H.-J.; Wang C.-C.; ANN-LII CHENG; Hsu C.; Lu Y.-S.; Chang M.-C.; Lin J.-T.; Wang H.-P.; Shiah H.-S.; Liu T.-W.; Chang J.-Y.; Whang-Peng J.; Chen L.-T. |
| 臺大學術典藏 |
2021-09-01T02:02:13Z |
Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer
|
Shiah H.-S.; ANN-LII CHENG; Hsu C.; Hsu C.-H.; Liu T.-W.; Chang J.-Y.; Jan C.-M.; Chao Y.; Yu W.-L.; Chuang T.-R.; Whang-Peng J.; Chen L.-T. |
| 臺大學術典藏 |
2021-09-01T01:54:18Z |
Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer
|
Ch'ang H.-J.; Huang C.-L.; Wang H.-P.; Shiah H.-S.; Chang M.-C.; Jan C.-M.; Chen J.-S.; Tien Y.-W.; Hwang T.-L.; Lin J.-T.; ANN-LII CHENG; Whang-Peng J.; Chen L.-T. |
| 臺大學術典藏 |
2021-09-01T01:54:14Z |
Clinical Development and Future Direction for the Treatment of Hepatocellular Carcinoma
|
Whang-Peng J.; ANN-LII CHENG; Hsu C.; Chen C.-M. |
| 臺大學術典藏 |
2021-09-01T01:54:08Z |
A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan
|
Chen J.-S.; Chao Y.; Hsieh R.-K.; ANN-LII CHENG; Chen P.-M.; Chiou T.-J.; Chao T.-Y.; Yeh K.-H.; Chen L.-T.; Whang-Peng J. |
| 臺大學術典藏 |
2021-09-01T01:54:05Z |
Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study
|
Ch'Ang H.-J.; Lin Y.-L.; Wang H.-P.; Chiu Y.-F.; Chang M.-C.; Hsu C.-H.; Tien Y.-W.; Chen J.-S.; Hsieh R.-K.; Lin P.-W.; Shan Y.-S.; ANN-LII CHENG; Chang J.-Y.; Whang-Peng J.; Hwang T.-L.; Chen L.-T. |
| 臺大學術典藏 |
2021-09-01T01:53:54Z |
The aurora kinases inhibitor VE-465 is a novel treatment for glioblastoma multiforme
|
Lee P.-Y.; Chen C.-L.; Lin Z.-Z.; ANN-LII CHENG; Chen E.I.-T.; Whang-Peng J.; Huang C.-Y.F. |
| 臺大學術典藏 |
2021-08-31T06:29:42Z |
A phase i clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment John T Kung
|
Liu K.-J.; Chao T.-Y.; Chang J.-Y.; ANN-LII CHENG; Ch'Ang H.-J.; Kao W.-Y.; Wu Y.-C.; Yu W.-L.; Chung T.-R.; Whang-Peng J. |
| 臺大學術典藏 |
2021-08-11T03:46:44Z |
The aurora kinases inhibitor VE-465 is a novel treatment for glioblastoma multiforme
|
Lee P.-Y.; Chen C.-L.; ZHONG-ZHE LIN; Cheng A.-L.; Chen E.I.-T.; Whang-Peng J.; Huang C.-Y.F. |
| 臺大學術典藏 |
2021-07-03T03:35:40Z |
Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma
|
Cheng A.-L.; Hsiung C.A.; Su I.-J.; PEI-JER CHEN; Chang M.-C.; Tsao C.-J.; Kao W.-Y.; Uen W.-C.; Hsu C.-H.; Tien H.-F.; Chao T.-Y.; Chen L.-T.; Whang-Peng J. |
| 臺大學術典藏 |
2021-07-03T03:35:21Z |
Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients
|
Su W.-P.; Wen C.-C.; Hsiung C.A.; Su I.-J.; Cheng A.-L.; Chang M.-C.; Tsao C.-J.; Kao W.-Y.; Uen W.-C.; Hsu C.-H.; Lu Y.-S.; Tien H.-F.; Chao T.-Y.; Chen L.-T.; Whang-Peng J.; PEI-JER CHEN |
| 臺大學術典藏 |
2021-07-03T03:35:20Z |
Phase I and pharmacokinetic study of oral thalidomide in patients with advanced hepatocellular carcinoma
|
Shiah H.-S.; Chao Y.; Chen L.-T.; Yao T.-J.; Huang J.-D.; Chang J.-Y.; PEI-JER CHEN; Chuang T.-R.; Chin Y.-H.; Whang-Peng J.; Liu T.-W. |
| 臺大學術典藏 |
2021-07-03T03:34:30Z |
Long-term results of a randomized, observation-controlled, phase III Trial of Adjuvant Interferon alfa-2b in hepatocellular carcinoma after curative resection
|
Chen L.-T.; Chen M.-F.; Li L.-A.; Lee P.-H.; Jeng L.-B.; Lin D.-Y.; Wu C.-C.; Mok K.-T.; Chen C.-L.; Lee W.-C.; Chau G.-Y.; Chen Y.-S.; Lui W.-Y.; Hsiao C.-F.; Whang-Peng J.; PEI-JER CHEN |
| 臺大學術典藏 |
2021-05-26T03:34:55Z |
Identification of α-enolase as an autoantigen in lung cancer: Its overexpression is associated with clinical outcomes
|
Chang G.-C.; Liu K.-J.; Hsieh C.-L.; Hu T.-S.; Charoenfuprasert S.; Liu H.-K.; KWEN-TAY LUH; Hsu L.-H.; Wu C.-W.; Ting C.-C.; Chen C.-Y.; Chen K.-C.; Yang T.-Y.; Chou T.-Y.; Wang W.-H.; Whang-Peng J.; Shih N.-Y. |
| 臺大學術典藏 |
2021-03-09T06:46:11Z |
Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma
|
Chan A.T.C.;Hsu M.-M.;Goh B.C.;Hui E.P.;Liu T.-W.;Millward M.J.;Ruey-Long Hong;Whang-Peng J.;Ma B.B.Y.;To K.F.;Mueser M.;Amellal N.;Lin X.;Chang A.Y.; Chan A.T.C.; Hsu M.-M.; Goh B.C.; Hui E.P.; Liu T.-W.; Millward M.J.; RUEY-LONG HONG; Whang-Peng J.; Ma B.B.Y.; To K.F.; Mueser M.; Amellal N.; Lin X.; Chang A.Y. |
| 臺大學術典藏 |
2021-03-05T06:07:34Z |
Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer
|
Ch'ang H.-J.; Wang C.-C.; Cheng A.-L.; Hsu C.; Lu Y.-S.; MING-CHU CHANG; Lin J.-T.; Wang H.-P.; Shiah H.-S.; Liu T.-W.; Chang J.-Y.; Whang-Peng J.; Chen L.-T. |
| 臺大學術典藏 |
2021-03-05T06:07:26Z |
Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer
|
Ch'ang H.-J.; Huang C.-L.; Wang H.-P.; Shiah H.-S.; MING-CHU CHANG; Jan C.-M.; Chen J.-S.; Tien Y.-W.; Hwang T.-L.; Lin J.-T.; Cheng A.-L.; Whang-Peng J.; Chen L.-T. |
| 臺大學術典藏 |
2021-03-05T06:07:25Z |
Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study
|
Ch'Ang H.-J.; Lin Y.-L.; Wang H.-P.; Chiu Y.-F.; MING-CHU CHANG; Hsu C.-H.; Tien Y.-W.; Chen J.-S.; Hsieh R.-K.; Lin P.-W.; Shan Y.-S.; Cheng A.-L.; Chang J.-Y.; Whang-Peng J.; Hwang T.-L.; Chen L.-T. |
| 臺大學術典藏 |
2021-02-23T08:26:42Z |
Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma
|
Chen L.-T.;Lin J.-T.;Tai J.J.;Chen G.-H.;Yeh H.-Z.;Yang S.-S.;Wang H.-P.;Sung-Hsin Kuo;Sheu B.-S.;Jan C.-M.;Wang W.-M.;Wang T.-E.;Wu C.-W.;Chen C.-L.;Su I.-J.;Whang-Peng J.;Cheng A.-L.; Chen L.-T.; Lin J.-T.; Tai J.J.; Chen G.-H.; Yeh H.-Z.; Yang S.-S.; Wang H.-P.; SUNG-HSIN KUO; Sheu B.-S.; Jan C.-M.; Wang W.-M.; Wang T.-E.; Wu C.-W.; Chen C.-L.; Su I.-J.; Whang-Peng J.; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-28T01:06:48Z |
Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and paclitaxel as first-line treatment
|
Yang C.-H.;Chen M.-C.;Cheng A.-L.;Hsu C.-H.;Kun-Huei Yeh;Yu Y.-C.;Whang-Peng J.;Yang P.-C.; Yang C.-H.; Chen M.-C.; Cheng A.-L.; Hsu C.-H.; KUN-HUEI YEH; Yu Y.-C.; Whang-Peng J.; Yang P.-C. |
| 臺大學術典藏 |
2021-01-28T01:06:41Z |
A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan
|
Chen J.-S.;Chao Y.;Hsieh R.-K.;Cheng A.-L.;Chen P.-M.;Chiou T.-J.;Chao T.-Y.;Kun-Huei Yeh;Chen L.-T.;Whang-Peng J.; Chen J.-S.; Chao Y.; Hsieh R.-K.; Cheng A.-L.; Chen P.-M.; Chiou T.-J.; Chao T.-Y.; KUN-HUEI YEH; Chen L.-T.; Whang-Peng J. |
| 臺大學術典藏 |
2021-01-15T03:47:46Z |
Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma
|
Chen L.-T.; Lin J.-T.; Tai J.J.; Chen G.-H.; Yeh H.-Z.; Yang S.-S.; HSIU-PO WANG; Kuo S.-H.; Sheu B.-S.; Jan C.-M.; Wang W.-M.; Wang T.-E.; Wu C.-W.; Chen C.-L.; Su I.-J.; Whang-Peng J.; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-15T03:47:43Z |
Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer
|
Ch'ang H.-J.; Wang C.-C.; Cheng A.-L.; Hsu C.; Lu Y.-S.; Chang M.-C.; Lin J.-T.; HSIU-PO WANG; Shiah H.-S.; Liu T.-W.; Chang J.-Y.; Whang-Peng J.; Chen L.-T. |
| 臺大學術典藏 |
2021-01-15T03:47:10Z |
Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer
|
Ch'ang H.-J.; Huang C.-L.; HSIU-PO WANG; Shiah H.-S.; Chang M.-C.; Jan C.-M.; Chen J.-S.; Tien Y.-W.; Hwang T.-L.; Lin J.-T.; Cheng A.-L.; Whang-Peng J.; Chen L.-T. |
| 臺大學術典藏 |
2021-01-15T03:47:00Z |
Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study
|
Ch'Ang H.-J.; Lin Y.-L.; HSIU-PO WANG; Chiu Y.-F.; Chang M.-C.; Hsu C.-H.; Tien Y.-W.; Chen J.-S.; Hsieh R.-K.; Lin P.-W.; Shan Y.-S.; Cheng A.-L.; Chang J.-Y.; Whang-Peng J.; Hwang T.-L.; Chen L.-T. |
| 臺大學術典藏 |
2021-01-04T12:13:01Z |
Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma
|
Whang-Peng J.; Chen L.-T.; HWEI-FANG TIEN; Chao T.-Y.; Hsu C.-H.; Uen W.-C.; Kao W.-Y.; Tsao C.-J.; Chang M.-C.; Chen P.-J.; Su I.-J.; Cheng A.-L.; Hsiung C.A. |
| 臺大學術典藏 |
2020-12-02T02:35:41Z |
Gefitinib reverses chemotherapy resistance in gefitinib-insensitive multidrug resistant cancer cells expressing ATP-binding cassette family protein
|
Yang C.-H.;Huang C.-J.;Yang C.-S.;Chu Y.-C.;Cheng A.-L.;Whang-Peng J.;Pan-Chyr Yang; Yang C.-H.; Huang C.-J.; Yang C.-S.; Chu Y.-C.; Cheng A.-L.; Whang-Peng J.; PAN-CHYR YANG |
| 臺大學術典藏 |
2020-12-02T02:35:41Z |
Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and paclitaxel as first-line treatment
|
PAN-CHYR YANG; Yang C.-H.;Chen M.-C.;Cheng A.-L.;Hsu C.-H.;Yeh K.-H.;Yu Y.-C.;Whang-Peng J.;Pan-Chyr Yang; Yang C.-H.; Chen M.-C.; Cheng A.-L.; Hsu C.-H.; Yeh K.-H.; Yu Y.-C.; Whang-Peng J. |
| 臺大學術典藏 |
2020-11-19T03:19:36Z |
Long-term results of a randomized, observation-controlled, phase III Trial of Adjuvant Interferon alfa-2b in hepatocellular carcinoma after curative resection
|
Chen L.-T.;Chen M.-F.;Li L.-A.;Po-Huang Lee;Jeng L.-B.;Lin D.-Y.;Wu C.-C.;Mok K.-T.;Chen C.-L.;Lee W.-C.;Chau G.-Y.;Chen Y.-S.;Lui W.-Y.;Hsiao C.-F.;Whang-Peng J.;Chen P.-J.; Chen L.-T.; Chen M.-F.; Li L.-A.; PO-HUANG LEE; Jeng L.-B.; Lin D.-Y.; Wu C.-C.; Mok K.-T.; Chen C.-L.; Lee W.-C.; Chau G.-Y.; Chen Y.-S.; Lui W.-Y.; Hsiao C.-F.; Whang-Peng J.; Chen P.-J. |
| 臺大學術典藏 |
2020-09-30T03:23:35Z |
Reappraisal of the early diagnostic value of serial analyses of Western Blot patterns for HIV infection in Neonates
|
Chen M.-Y.;Chien-Ching Hung;Lin Y.G.;Lin R.-Y.;Twu S.-J.;Ko Y.-C.;Ho H.-N.;Lin C.-P.;Huang S.-F.;Kerrigan M.E.;Whang-Peng J.;Chuang C.-Y.;Chang K.S.S.;Sung J.-L.;Chang H.-J.;Shih Y.-T.;Chang P.-Y.; Chen M.-Y.; CHIEN-CHING HUNG; Lin Y.G.; Lin R.-Y.; Twu S.-J.; Ko Y.-C.; Ho H.-N.; Lin C.-P.; Huang S.-F.; Kerrigan M.E.; Whang-Peng J.; Chuang C.-Y.; Chang K.S.S.; Sung J.-L.; Chang H.-J.; Shih Y.-T.; Chang P.-Y. |
| 國家衛生研究院 |
2020-09-13 |
Astragalus Polysaccharide (PG2) suppresses macrophage migration inhibitory factor and aggressiveness of lung adenocarcinoma cells
|
Liao, CH;Yong, CY;Lai, GM;Chow, JM;Cheng, CF;Fang, CL;Lin, PC;Chang, CL;Zheng, YM;Chuang, SE;Whang-Peng, J;Yao, CJ |
| 國家衛生研究院 |
2020-07-29 |
Omega-3 fatty acid-enriched fish oil and selenium combination modulates endoplasmic reticulum stress response elements and reverses acquired gefitinib resistance in HCC827 lung adenocarcinoma cells
|
Liao, CH;Tzeng, YT;Lai, GM;Chang, CL;Hu, MH;Tsai, WL;Liu, YR;Hsia, S;Chuang, SE;Chiou, TJ;Wang, LM;Whang-Peng, J;Yao, CJ |
| 臺大學術典藏 |
2020-05-26T09:27:28Z |
Gefitinib reverses chemotherapy resistance in gefitinib-insensitive multidrug resistant cancer cells expressing ATP-binding cassette family protein
|
Chih-Hsin Yang;Huang C.-J;Yang C.-S;Chu Y.-C;Cheng A.-L;Whang-Peng J;Yang P.-C.; CHIH-HSIN YANG; Huang C.-J; Yang C.-S; Chu Y.-C; Cheng A.-L; Whang-Peng J; Yang P.-C. |
